- About
- Advertise / Support
- Contact
- CancerNetwork.com
- TargetedOnc.com
- OncLive.com
- OncNursingNews.com
- Terms & Conditions
- Privacy
- Do Not Sell My Information
© 2025 MJH Life Sciences™ and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
Latest Conference Articles
Quadruplet Regimen Preferable to Triplets in Multiple Myeloma
March 27th 2025, 7:00pm
Educated Patient® Multiple Myeloma Summit
Dr. Cesar Rodriguez discussed treatment advancements for multiple myeloma during a CURE Educated Patient® Summit.
Communication is Key When Transitioning Multiple Myeloma Care
March 26th 2025, 7:00pm
Educated Patient® Multiple Myeloma Summit
A panel of experts discussed the transition of care between community and academic centers at the CURE Educated Patient Multiple Myeloma Summit.
Top 3 Takeaways From ASCO GU 2025
March 25th 2025, 8:16pm
Dr. Emre Yekedüz discusses his top 3 key takeaways from attending the 2025 ASCO Genitourinary (GU) Cancers Symposium.
Emphasizing the Importance of Breast Cancer Education and Screenings
March 21st 2025, 7:00pm
Miami Breast Cancer Conference and Educated Patient Breast Cancer Summit
Registered nurse Patricia Jakel emphasizes the importance of educating patients on evolving breast cancer research and the need for routine screenings.
Evolving Treatments and Advances in HER2-Positive Breast Cancer
March 20th 2025, 9:00pm
Miami Breast Cancer Conference and Educated Patient Breast Cancer Summit
Dr. Sara M. Tolaney discussed HER2-positive breast cancer, highlighting key trials, evolving treatment strategies, and the potential for improved outcomes.
The Power of Knowledge and Staying Informed in Breast Cancer Care
March 20th 2025, 8:00pm
Miami Breast Cancer Conference and Educated Patient Breast Cancer Summit
Dr. Debu Tripathy highlights the importance of staying informed on breast cancer advancements and how this empowers patients to make informed decisions.
What Patients With Breast Cancer Need to Know About Itovebi
March 20th 2025, 7:05pm
Miami Breast Cancer Conference and Educated Patient Breast Cancer Summit
Itovebi, approved for some patients with breast cancer, is the first PI3K inhibitor to display a survival benefit, according to Dr. Kevin Kalinsky.
Gene Expression Testing and Targeted Therapies in Breast Cancer Care
March 19th 2025, 9:00pm
Miami Breast Cancer Conference and Educated Patient Breast Cancer Summit
Gene expression testing helps determine chemotherapy needs for HR+ breast cancer, optimizing treatment and reducing unnecessary toxicity.
Understanding Genetic and Genomic Testing in Breast Cancer
March 18th 2025, 8:01pm
Miami Breast Cancer Conference and Educated Patient Breast Cancer Summit
Genetic and genomic testing guide breast cancer risk assessment and treatment, as discussed by Dr. Mark Robson at the Miami Breast Cancer Summit.
Why It’s Important to Have Hard Conversations in Breast Cancer Care
March 16th 2025, 2:00pm
Miami Breast Cancer Conference and Educated Patient Breast Cancer Summit
CURE spoke with Kelly Grosklags of Conversations With Kelly at the Miami Breast Cancer Conference.